Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/15/2025
Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
5/15/2025
NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
5/15/2025
Hengrui Aims to Raise $1.27B in Hong Kong IPO
5/14/2025
NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
5/14/2025
BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...
5/14/2025
Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
5/14/2025
RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
5/14/2025
CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
5/14/2025
Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
5/14/2025
Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
5/14/2025
R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
5/14/2025
CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
5/14/2025
Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
5/13/2025
China Expands Geriatric Services at Major Hospitals as Elderly Populat...
5/12/2025
Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
5/12/2025
AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...
5/12/2025
CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...
5/12/2025
CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...
5/12/2025
China Biopharma Financing Drops in April 2025, Signals Investor Cautio...
5/12/2025
EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...
5/12/2025
Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...
5/12/2025
METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
5/12/2025
Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...
5/12/2025
Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
5/10/2025
~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
5/10/2025
China's BMI Fund Reports Big Surplus in Q1/2025
5/10/2025
Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
5/10/2025
AstraZeneca Launches $475M Small Molecule Drug Plant Project in Wuxi t...
5/10/2025
Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
5/10/2025
China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
Page:
6
/
770
Total number of articles:
23098
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit